Literature DB >> 18267220

Biomarker responses during mid-term mechanical cardiac support in children.

Grit Heise1, Julia Lemmer, Yuguo Weng, Michael Hübler, Vladimir Alexi-Meskishvili, Wolfgang Böttcher, Roland Hetzer, Felix Berger, Brigitte Stiller.   

Abstract

BACKGROUND: The purpose of this study was to determine the effect of mid-term mechanical circulatory support on the natriuretic hormone system in children and to assess whether such changes are associated with myocardial recovery.
METHODS: Serial blood samples were collected from 19 children (median age 10.8 years, range 0.2 to 17.5 years), all supported with a pulsatile ventricular assist device (Berlin Heart EXCOR; median support time 55 days). Levels of NT-proBNP were analyzed before and 7 and 30 days after device implantation. In addition, we determined levels of mid-region proANP (MR-proANP) and BNP in 13 of the 19 children.
RESULTS: The actuarial survival rate to discharge home was 84%. Two children could be weaned from the system, 14 reached heart transplantation, and 3 died during mechanical circulatory support. Serial measurements of NT-proBNP, BNP and MR-proANP showed a significant down-regulation of all three natriuretic peptides within the first week of support and a further decrease between Days 7 and 30. The lowest NT-proBNP level while on the device (250 pg/ml) was found in the child later weaned, who reached normal levels (71 pg/ml) within 12 weeks after weaning.
CONCLUSIONS: Extremely high levels of natriuretic peptides reflect the severity of myocardial failure before device implantation. During mechanical support, the decline of natriuretic peptides appears to be a helpful additional tool in the pre-selection of potential weaning candidates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18267220     DOI: 10.1016/j.healun.2007.11.564

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

Review 1.  Interpretation and use of natriuretic peptides in non-congestive heart failure settings.

Authors:  Shih-Hung Tsai; Yen-Yue Lin; Shi-Jye Chu; Ching-Wang Hsu; Shu-Meng Cheng
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

Review 2.  The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

Authors:  Massimiliano Cantinotti; Yuk Law; Simona Vittorini; Maura Crocetti; Marotta Marco; Bruno Murzi; Aldo Clerico
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

3.  Circulating biomarker responses to medical management vs. mechanical circulatory support in severe inotrope-dependent acute heart failure.

Authors:  Anna J Meredith; Darlene L Y Dai; Virginia Chen; Zsuzsanna Hollander; Raymond Ng; Annemarie Kaan; Scott Tebbutt; Krishnan Ramanathan; Anson Cheung; Bruce M McManus
Journal:  ESC Heart Fail       Date:  2015-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.